Results 31 to 40 of about 90,332 (308)

Mechanisms underlying the initiation of cerebral betaamyloidosis and neurofibrillary tau pathology : new insights form transgenic mice [PDF]

open access: yes, 2006
Numerous neurodegenerative disorders result from the aggregation of proteins that misfold and accumulate as fibrillar amyloid deposits in selectively vulnerable regions of the central nervous system.
Bolmont, Tristan
core   +1 more source

Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis. [PDF]

open access: yes, 2020
Systemic amyloidosis is a heterogeneous group of diseases associated with protein misfolding into insoluble beta-sheet rich structures that deposit extracellularly in different organs, eventually compromising their function.
Monney, P.   +140 more
core   +1 more source

Management of transthyretin amyloidosis. [PDF]

open access: yes, 2021
Transthyretin amyloidosis (ATTR amyloidosis) is a disease caused by deposition of transthyretin fibrils in organs and tissues, which causes their dysfunction.
Monney, P.   +136 more
core   +1 more source

A retrospective study of isatuximab-pomalidomide-dexamethasone in relapsed/refractory systemic AL amyloidosis

open access: yesHaematologica
Not available.
Sargam Rachit Vohra   +11 more
doaj   +1 more source

Hereditary amyloidosis [PDF]

open access: yesArthritis & Rheumatism, 1970
AbstractA review of hereditary amyloidoses is provided by papers from a 1969 international symposium on primary amyloidosis. These discussions allow comparison of the amyloid neuropathy with onset in the lower extremities (Portuguese‐Japanese families), the neuropathy with onset in the upper extremities (Indiana‐Maryland families), the neuropathy and ...
C, Andrade   +9 more
openaire   +2 more sources

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome

open access: yes, 2013
Background Cardiac amyloidosis is a fatal disease whose prognosis and treatment rely on identification of the amyloid type. In our aging population transthyretin amyloidosis (ATTRwt) is common and must be differentiated from other amyloid types.
Banypersad, SM   +15 more
core   +1 more source

Role of cardiac MRI in the diagnosis of cardiac amyloidosis. Clinical cases

open access: yes, 2021
Purpose. The aim of this work is to show the capabilities of late gadolinium enhancement cardiac magnetic resonance imaging (MRI) in the diagnosis of a rare disease such as cardiac amyloidosis. Materials and methods.
Olga V. Stukalova, Ekaterina A. Butorova
core   +1 more source

Predictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...
Miquel Massons   +33 more
wiley   +1 more source

Misdiagnosis of hereditary amyloidosis as AL (Primary) amyloidosis [PDF]

open access: yes, 2002
Background: Hereditary, autosomal dominant amyloidosis, caused by mutations in the genes encoding transthyretin, fibrinogen A -chain, lysozyme, or apolipoprotein A-I, is thought to be extremely rare and is not routinely included in the differential ...
Booth, D.R.   +7 more
core  

Neurodegeneration and neurogenesis in mouse models of aging and Alzheimer's disease [PDF]

open access: yes, 2003
As the proportion of senior citizens gradually increases, the behavioral changes that occur with normal aging and as a consequence of Alzheimer’s disease (AD) will afflict many of us in the future.
Bondolfi, Luca E.
core   +1 more source

Home - About - Disclaimer - Privacy